Camrelizumab combined with apatinib as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: A phase 2 trial

被引：0
|
作者：
Meng, Xiangrui [1 ]
Qi, Yu [1 ]
Shan, Zhengzheng [1 ]
Yang, Yang [1 ]
Fan, Qingxia [1 ]
Wang, Feng [1 ]
机构：
[1] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16087
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant camrelizumab plus chemotherapy for resectable, locally advanced esophageal squamous cell carcinoma (NIC-ESCC2019): A multicenter, phase 2 study
    Liu, Jun
    Li, Jingpei
    Lin, Wanli
    Shao, Di
    Depypere, Lieven
    Zhang, Zhifeng
    Li, Zhuoyi
    Cui, Fei
    Du, Zesen
    Zeng, Yuan
    Jiang, Shunjun
    He, Ping
    Gu, Xia
    Chen, Huai
    Zhang, Hai
    Lin, Xiaowei
    Huang, Haoda
    Lv, Wenqiang
    Cai, Weiming
    Liang, Wenhua
    Liang, Hengrui
    Jiang, Wenxi
    Wang, Wei
    Xu, Ke
    Cai, Weipeng
    Wu, Kui
    Lerut, Toni
    Fu, Junhui
    He, Jianxing
    INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (01) : 128 - 137
  • [42] Clinical study of camrelizumab combined with docetaxel and carboplatin in neoadjuvant treatment of locally advanced oesophageal squamous cell carcinoma
    Wang, R.
    Zhang, G.
    Zhu, Q.
    Ma, T.
    Weng, C.
    Zhang, D.
    Zeng, H.
    Wang, T.
    Gao, F.
    Mi, L.
    ANNALS OF ONCOLOGY, 2023, 34 : S866 - S866
  • [43] Clinical study of camrelizumab combined with docetaxel and carboplatin as a neoadjuvant treatment for locally advanced oesophageal squamous cell carcinoma
    Zhang, Guo-Liang
    Zhu, Qi-Kun
    Ma, Tian-You
    Weng, Chen-Gang
    Zhang, Dan-Dan
    Zeng, Hui
    Wang, Tao
    Gao, Feng
    Mi, Li-Li
    Wang, Rui
    DISEASES OF THE ESOPHAGUS, 2024, 37 (04)
  • [44] Inductive camrelizumab and apatinib for patients with locally advanced and resectable oral squamous cell carcinoma: A single-arm trial (Icemelting trial).
    Zhong, Lai-Ping
    Ju, Wu-tong
    Xia, Rong-hui
    Zhu, Qi
    Zhu, Guopei
    Dou, Shengjin
    Li, Jiang
    Dong, Min-jun
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Yu, Yong-kui
    Meng, Fan-Yu
    Wei, Xiu-feng
    Chen, Xian-kai
    Li, Hao-miao
    Liu, Qi
    Li, Can-jun
    Xie, Hou-nai
    Xu, Lei
    Zhang, Rui-xiang
    Xing, Wenqun
    Li, Yin
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2024, 168 (02):
  • [46] Safety and Feasibility of Radiotherapy Plus Camrelizumab for Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhang, Wencheng
    Yan, Cihui
    Gao, Xuan
    Li, Xiaoxia
    Cao, Fuliang
    Zhao, Gang
    Zhao, Jingjing
    Er, Puchun
    Zhang, Tian
    Chen, Xi
    Wang, Yuwen
    Jiang, Yao
    Wang, Quanren
    Zhang, Baozhong
    Qian, Dong
    Wang, Jun
    Zhou, Dejun
    Ren, Xiubao
    Yu, Zhentao
    Zhao, Lujun
    Yuan, Zhiyong
    Wang, Ping
    Pang, Qingsong
    ONCOLOGIST, 2021, 26 (07): : E1110 - E1124
  • [47] CRIA: Phase II Trial of Induction and Adjuvant Camrelizumab Combined with Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma
    Zhang, X.
    Wang, Y.
    Sui, J.
    Luo, Q.
    Lei, Q.
    Shu, X.
    Long, B.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E283 - E283
  • [48] Phase II trial of terelizumab combined with radiotherapy of locally advanced unresectable esophageal squamous cell carcinoma: TREC trial
    Liu, Changmin
    Yu, Zeshun
    Hao, Yanzhang
    Wang, Feng
    Wang, Zhenbo
    Tian, Lijun
    Wang, Yue
    Ning, Fangling
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Results of Neoadjuvant Chemoradiation Therapy Followed by Surgery for Locally Advanced Esophageal Squamous Cell Carcinoma
    Murakami, Y.
    Nobuki, I.
    Doi, Y.
    Okabe, T.
    Kenjo, M.
    Kaneyasu, Y.
    Kimura, T.
    Hihara, J.
    Nagata, Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S337 - S337
  • [50] The survival outcomes of neoadjuvant sintilimab combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
    Lv, Huilai
    Huang, Chao
    Li, Jiachen
    Zhang, Fan
    Gai, Chunyue
    Liu, Zhao
    Xu, Shi
    Wang, Mingbo
    Li, Zhenhua
    Tian, Ziqiang
    FRONTIERS IN IMMUNOLOGY, 2023, 13
12345